FREE Account Opening + No Clearing Fees
Loading...
September 25, 2007 - September 28, 2007

Saamya Biotech IPO Latest News Today

Track all the latest updates and news of Saamya Biotech IPO.

  1. Third Rock, J&J neuroscience spinout Rapport is first biotech to outline summer IPO plans

    May 20, 2024 12:43:00 PM

    The new year burst of biotech IPOs may have sputtered out months ago, but Rapport Therapeutics is a reminder that companies are still willing to test the waters of the public markets. | The new year ...

    Published by : FierceBiotech
  2. Next wave of IPOs will arrive in summer, predicts biotech-focused VC partner

    May 3, 2024 2:20:00 PM

    Delegates at the LSX World Conference in London this week seemed to agree on one thing�the biotech IPO window finally re-opened this year. This sentiment has persisted despite the fact that the ...

    Published by : FierceBiotech
  3. Oyo, once valued at $10 billion, shelves IPO plans for second time

    May 22, 2024 8:19:00 PM

    India's Oyo, once valued at $10 billion, has withdrawn its IPO application from the market regulator for the second time.

    Published by : TechCrunch
  4. Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasnt fully recovered just yet

    April 23, 2024 7:35:00 PM

    Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! After a two-year dry spell, initial public offerings by biotech companies showed ...

    Published by : MSN
  5. Beyond the biotech IPO: a brave new world

    October 12, 2023 9:50:00 PM

    After a decade of significant challenges, biotech's long-term sustainability depends on making fundamental changes to its traditional business model. A commonly held perception in the biotech ...

    Published by : Nature
  6. IPO Preview: Legend Biotech Seeks U.S. IPO

    May 19, 2020 3:30:00 AM

    Legend Biotech is spinning out from parent firm GenScript Biotech to pursue treatments in CAR T cell therapies for multiple myeloma. Legend Biotech is spinning out from parent firm GenScript ...

    Published by : TheStreet.com
  7. Biotech IPOs bounced back in first quarter, but backlog remains

    April 12, 2024 10:33:00 AM

    The sum is more than three times the $375 million in total proceeds from biotech IPOs in the first quarter last year, and roughly matches the first quarter total in 2020. Six of the nine biotechs ...

    Published by : Yahoo Finance
  8. Contineum prices biotech�s latest IPO, raising $110M for neuroinflammatory drugs

    April 4, 2024 9:58:00 PM

    Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By this time last year, only four drug startups had gone public, raising $375 ...

    Published by : Yahoo Finance
  9. Contineum prices biotech�s latest IPO, raising $110M for neuroinflammatory drugs

    April 10, 2024 11:07:00 AM

    It�ll begin trading on the Nasdaq stock exchange on Friday under the symbol �CTNM.� Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By ...

    Published by : Yahoo Finanzas

Saamya Biotech IPO Alerts

1. Saamya Biotech India Limited IPO - Listing  Friday, October 19, 2007 12:00:00 AM

Saamya Biotech India Limited IPO listing info:

IPO Listing Date: Friday, October 19, 2007
BSE Script Code: 532905
Listing in: B1 Group
ISIN: INE320H01019
Issue Price: Rs 10/- Per Equity Share
Face Value : Rs 10/- Per Equity Share

2. Saamya Biotech India Limited IPO Allotment Status  Thursday, October 18, 2007 10:45:00 AM

IPO Allotment Status is now available online for Saamya Biotech India Limited.

Saamya Biotech India Limited IPO was closed on September 28, 2007.

 

3. Saamya Biotech India Limited IPO listing date & info  Thursday, October 18, 2007 8:36:00 AM

Saamya Biotech India Limited IPO listing info:

IPO Listing Date: Friday, October 19, 2007
BSE Script Code: 532905
Listing in: B1 Group
ISIN: INE320H01019
Issue Price: Rs 10/- Per Equity Share
Face Value : Rs 10/- Per Equity Share

4. Saamya Biotech India Limited IPO - Allotment  Thursday, October 18, 2007 12:00:00 AM

IPO Allotment Status is now available online for Saamya Biotech India Limited.

Saamya Biotech India Limited IPO was closed on September 28, 2007.

5. Saamya Biotech India Limited IPO - Close  Friday, September 28, 2007 12:00:00 AM

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.

The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

6. Saamya Biotech India Limited IPO - Open  Tuesday, September 25, 2007 12:00:00 AM

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.

The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

7. Saamya Biotech IPO opening on Sept 25  Tuesday, September 18, 2007 2:27:00 PM

Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.

SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.
 
The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

Saamya Biotech IPO News & Events FAQs

The Saamya Biotech IPO is proposed to open on September 25, 2007. The IPO application ends on September 28, 2007.

Retail investors can apply in the retail or non-institutional investor category from September 25, 2007 to September 28, 2007. The Saamya Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Saamya Biotech IPO will open for subscription on September 25, 2007. The public issue will close on September 28, 2007.